Rocket Pharmaceuticals logo

Rocket Pharmaceuticals Share Price Today

(NASDAQ: RCKT)

Rocket Pharmaceuticals share price is $9.21 & ₹800.98 as on 6 Mar 2025, 2.30 'hrs' IST

$9.21

0.55

(6.35%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Rocket Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rocket Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rocket Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Rocket Pharmaceuticals share price movements

  • Today's Low: $8.76
    Today's High: $9.35

    Day's Volatility :6.31%

  • 52 Weeks Low: $8.64
    52 Weeks High: $28.73

    52 Weeks Volatility :69.94%

Rocket Pharmaceuticals (RCKT) Returns

PeriodRocket Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-34.98%
2.1%
0.0%
6 Months
-53.26%
-4.1%
0.0%
1 Year
-68.82%
2.2%
0.0%
3 Years
-41.57%
11.8%
-11.6%

Rocket Pharmaceuticals (RCKT) Key Statistics

in dollars & INR

Previous Close
$8.66
Open
$8.71
Today's High
$9.35
Today's Low
$8.76
Market Capitalization
$923.4M
Today's Volume
$538.4K
52 Week High
$28.73
52 Week Low
$8.635
Revenue TTM
$0.0
EBITDA
$-263.8M
Earnings Per Share (EPS)
$-2.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-54.14%

How to invest in Rocket Pharmaceuticals Stock (RCKT) from India?

It is very easy for Indian residents to invest directly in Rocket Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rocket Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rocket Pharmaceuticals or RCKT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rocket Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rocket Pharmaceuticals shares which would translate to 0.094 fractional shares of Rocket Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rocket Pharmaceuticals, in just a few clicks!

Returns in Rocket Pharmaceuticals (RCKT) for Indian investors in Rupees

The Rocket Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rocket Pharmaceuticals investment value today

Current value as on today

₹38,128

Returns

₹61,872

(-61.87%)

Returns from Rocket Pharmaceuticals Stock

₹66,835 (-66.83%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Rocket Pharmaceuticals (RCKT)

-52%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Rocket Pharmaceuticals Stock from India on INDmoney has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rocket Pharmaceuticals

  • RTW INVESTMENTS, LLC

    16.59%

  • Wellington Management Company LLP

    13.13%

  • BlackRock Inc

    6.66%

  • Vanguard Group Inc

    6.17%

  • Maverick Capital Ltd

    4.88%

  • Westfield Capital Management Company, L.P.

    4.42%

Analyst Recommendation on Rocket Pharmaceuticals

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 21 Wall street analysts offering stock ratings for Rocket Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
19
Hold
2
1
1
Sell
0
0
0

Analyst Forecast on Rocket Pharmaceuticals Stock (RCKT)

What analysts predicted

Upside of 344.39%

Target:

$40.93

Current:

$9.21

Insights on Rocket Pharmaceuticals Stock (Ticker Symbol: RCKT)

  • Price Movement

    In the last 6 months, RCKT stock has moved down by -53.3%
  • RCKT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 130.9%
  • RCKT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 88.8%

Rocket Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rocket Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rocket Pharmaceuticals (RCKT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rocket Pharmaceuticals Inc logo
-17.99%
-53.26%
-68.82%
-41.57%
-52.0%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rocket Pharmaceuticals Inc logo
NA
NA
NA
-2.23
-0.54
-0.31
NA
4.35
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rocket Pharmaceuticals Inc logo
Buy
$923.4M
-52.0%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Rocket Pharmaceuticals

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy, an inheritable cardiac disorder; and BAG3 Dilated Cardiomyopathy. It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
Organization
Rocket Pharmaceuticals
Employees
299
CEO
Dr. Gaurav D. Shah M.D.
Industry
Health Technology

Management People of Rocket Pharmaceuticals

NameTitle
Dr. Gaurav D. Shah M.D.
CEO & Director
Ms. Kinnari Patel M.B.A., Pharm.D.
Head of R&D, President & COO
Mr. Mayo Pujols
Chief Technical Officer
Mr. Jonathan Schwartz M.D.
Chief Medical & Gene Therapy Officer
Mr. Aaron Ondrey
Chief Financial Officer
Mr. Martin Louis Wilson J.D.
General Counsel, Chief Compliance Officer & Chief Corporate Officer
Kevin Giordano
Director of Corporate Communications
Ms. Isabel Carmona J.D.
Chief People Officer
Dr. Gayatri R. Rao J.D., M.D.
Senior VP of Clinical Safety & Chief Regulatory Officer
Mr. Raj Prabhakar M.B.A.
Chief Business Officer

Important FAQs about investing in RCKT Stock from India :

What is Rocket Pharmaceuticals share price today?

Rocket Pharmaceuticals share price today stands at $9.21, Open: $8.71 ; Previous Close: $8.66 ; High: $9.35 ; Low: $8.76 ; 52 Week High: $28.73 ; 52 Week Low: $8.64.

The stock opens at $8.71, after a previous close of $8.66. The stock reached a daily high of $9.35 and a low of $8.76, with a 52-week high of $28.73 and a 52-week low of $8.64.

Can Indians buy Rocket Pharmaceuticals shares?

Yes, Indians can invest in the Rocket Pharmaceuticals (RCKT) from India.

With INDmoney, you can buy Rocket Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rocket Pharmaceuticals at zero transaction cost.

How can I buy Rocket Pharmaceuticals shares from India?

It is very easy to buy Rocket Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rocket Pharmaceuticals (RCKT) be purchased?

Yes, you can buy fractional shares of Rocket Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rocket Pharmaceuticals stocks?

To start investing in Rocket Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rocket Pharmaceuticals Stock (RCKT)?

Today’s highest price of Rocket Pharmaceuticals (RCKT) is $9.35.

Today’s lowest price of Rocket Pharmaceuticals (RCKT) is $8.76.

What is today's market capitalisation of Rocket Pharmaceuticals?

Today's market capitalisation of Rocket Pharmaceuticals RCKT is 923.4M

What is the 52 Week High and Low Range of Rocket Pharmaceuticals Stock (RCKT)?

  • 52 Week High

    $28.73

  • 52 Week Low

    $8.64

What are the historical returns of Rocket Pharmaceuticals (RCKT)?

  • 1 Month Returns

    -17.99%

  • 3 Months Returns

    -53.26%

  • 1 Year Returns

    -68.82%

  • 5 Years Returns

    -52%

Who is the Chief Executive Officer (CEO) of Rocket Pharmaceuticals ?

Dr. Gaurav D. Shah M.D. is the current Chief Executive Officer (CEO) of Rocket Pharmaceuticals.